Diagnosis and treatment progress of Hodgkin lymphoma
10.3760/cma.j.issn.1006-9801.2019.03.018
- VernacularTitle:霍奇金淋巴瘤诊疗进展
- Author:
Wenjia SU
1
;
Shuye WANG
Author Information
1. 哈尔滨医科大学附属第一医院血液内科 150001
- Keywords:
Lymphoma,non-Hodgkin;
Neoplasm staging;
Targeted therapy;
Combined chemotherapy;
Prognosis
- From:
Cancer Research and Clinic
2019;31(3):213-216
- CountryChina
- Language:Chinese
-
Abstract:
Hodgkin lymphoma (HL) is a kind of malignant tumors originating from lymphoid hemopoietic tissues and often involves lymphatic system.HL is a kind of highly curable lymphomas,and the assessment of prognostic factors is important for the diagnosis and treatment of this disease.In recent years,the international research focuses on the reasonable and individualized comprehensive treatment mode of radiotherapy and chemotherapy,the exploration of new drugs and new chemotherapy protocols,in order to further improve the survival rate of patients.Staging criteria from several research organizations have played the guiding role in the therapeutic strategy of risk adjustment.Some researches have proposed low toxic and effective combined chemotherapy regimens,radiotherapy and new targeted drugs guided by positron-emission tomography.Combined with the National Comprehensive Cancer Network (NCCN) in 2017 guidelines,this paper reviews the progresses of clinicopathological manifestations,differential diagnosis and treatment regimens of HL.
